(2026). Ponatinib confers adult human cardiomyocyte toxicity via inhibition of AKT signaling. Physiological Reports.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Ponatinib Confers Adult Human Cardiomyocyte Toxicity via Inhibition of AKT Signaling."
Physiological Reports 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Ponatinib Confers Adult Human Cardiomyocyte Toxicity via Inhibition of AKT Signaling."
Physiological Reports, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.